Lineage Cell Therapeutics (LCTX) Non-Current Debt (2015 - 2017)
Lineage Cell Therapeutics (LCTX) reported Non-Current Debt of $18000.0 for Q4 2017, down 85.0% on a YoY basis from $120000.0 in Q4 2016, and down 59.09% quarter-over-quarter from $44000.0 in Q3 2017.
Lineage Cell Therapeutics (LCTX) Non-Current Debt (2015 - 2017) Analysis & Trends
Lineage Cell Therapeutics has reported Non-Current Debt for 3 years, with the latest figure at $18000.0 in Q4 2017.
- For the quarter ending Q4 2017, Non-Current Debt fell 85.0% year-over-year to $18000.0; the trailing twelve-month figure through Dec 2017 stood at $18000.0 (down 85.0% YoY), and the FY2017 full-year result was $18000.0, down 85.0% from the prior year.
- Non-Current Debt for Q4 2017 stood at $18000.0, down from $44000.0 in the prior quarter.
- The five-year high for Non-Current Debt was $268000.0 in Q3 2015, with the low at $18000.0 in Q4 2017.
- Historically, Non-Current Debt has averaged $142600.0 across 3 years, with a median of $146500.0 in 2016.
- Annual changes were most pronounced in 2016 — Non-Current Debt slumped 35.45% — and 2017, when it tumbled 85.0%.
- Lineage Cell Therapeutics' Non-Current Debt stood at $220000.0 in 2015, then sank by 45.45% to $120000.0 in 2016, then plunged by 85.0% to $18000.0 in 2017.
- The last three Non-Current Debt figures came in at $18000.0 (Q4 2017), $44000.0 (Q3 2017), and $95000.0 (Q2 2017), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 319.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Lineage Cell Therapeutics | 303.84 Mn | 239.94 Mn | 1.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 18,000.00 |
| Dec 31, 2017 | 18,000.00 |
| Sep 30, 2017 | 44,000.00 |
| Sep 30, 2017 | 44,000.00 |
| Jun 30, 2017 | 95,000.00 |
| Jun 30, 2017 | 95,000.00 |
| Mar 31, 2017 | 95,000.00 |
| Mar 31, 2017 | 95,000.00 |
| Dec 31, 2016 | 120,000.00 |
| Dec 31, 2016 | 120,000.00 |
| Sep 30, 2016 | 173,000.00 |
| Sep 30, 2016 | 173,000.00 |
| Jun 30, 2016 | 173,000.00 |
| Jun 30, 2016 | 173,000.00 |
| Mar 31, 2016 | 220,000.00 |
| Mar 31, 2016 | 220,000.00 |
| Dec 31, 2015 | 220,000.00 |
| Dec 31, 2015 | 220,000.00 |
| Sep 30, 2015 | 268,000.00 |
| Sep 30, 2015 | 268,000.00 |